C-82

N/A

Report date: 2022/10/23 13:38:02
NME

Base Information

Drug NameC-82
Drug Alias NameC-82PRI-724 prodrug
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActioncAMP-response element binding protein inhibitorsWnt signalling pathway inhibitorsCatenin beta 1 inhibitors
TargetscAMP-response element binding proteinCatenin beta 1
Therapy Area/IndicationsPsoriasisScleroderma, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPrism Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPrism Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsPsoriasisScleroderma, Systemic

Other Information

ATC CodeN/A
Related LinksN/A